Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance
Asparaginase is one of the most important chemotherapeutic agents against pediatric acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. The therapeutic efficacy (e.g., chemoresistance) and adverse effects of asparaginase (e.g., hypersensivity and pancreatitis) have been inv...
Saved in:
| Main Author: | Shih-Hsiang Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2015-10-01
|
| Series: | Pediatrics and Neonatology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957214001983 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment
by: T. T. Valiev
Published: (2023-09-01) -
Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol
by: M. Yu. Goroshkova, et al.
Published: (2022-11-01) -
Risk factors and outcome of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia
by: Seham Hassan, et al.
Published: (2025-06-01) -
Expert recommendations for pancreatitis/pancreatic necrosis treatment after L-asparaginase in children with acute lymphoblastic leukemia
by: T. T. Valiev, et al.
Published: (2024-04-01) -
Successful treatment of pancreatitis caused by L-asparaginase in clinical practice
by: Yu. S. Korkina, et al.
Published: (2024-01-01)